Biosergen (BIOSGN.ST) Stock Price

Biosergen Price

CLOSED
1.25SEK-0.77 (-47.09 %)
Market closed

The stock trades about 104% above its 52-week low.

Biosergen stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Biosergen over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Biosergen stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Biosergen's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Biosergen Stock Price History
DateBiosergen Price
8/11/20261.25 SEK
8/10/20262.02 SEK
8/7/20262.78 SEK
8/6/20260.66 SEK
8/5/20260.64 SEK
8/4/20260.61 SEK
7/31/20260.66 SEK
7/30/20260.66 SEK
7/29/20260.68 SEK
7/28/20260.68 SEK
7/27/20266.50 SEK
7/24/20266.70 SEK
7/23/20266.50 SEK
7/22/20266.50 SEK
7/21/20266.25 SEK
7/20/20265.85 SEK
7/17/20265.85 SEK
7/15/20265.85 SEK
7/14/20266.05 SEK
7/13/20266.05 SEK
7/10/20266.25 SEK
7/9/20266.70 SEK
7/8/20266.70 SEK
7/7/20265.50 SEK
7/6/20265.30 SEK
7/3/20265.20 SEK
7/2/20265.00 SEK
7/1/20264.70 SEK
6/30/20264.82 SEK
6/29/20264.66 SEK
6/26/20264.66 SEK
6/25/20264.66 SEK
6/24/20264.66 SEK
6/23/20264.85 SEK
6/22/20264.85 SEK
6/18/20264.69 SEK
6/17/20264.69 SEK
6/16/20264.72 SEK
6/15/20264.72 SEK
6/12/20264.72 SEK
6/11/20265.03 SEK
6/10/20265.06 SEK
6/9/20265.03 SEK
6/8/20265.03 SEK
6/5/20265.53 SEK
6/4/20265.53 SEK
6/3/20265.53 SEK
6/2/20265.53 SEK
6/1/20265.81 SEK
5/29/20265.59 SEK
5/28/20265.59 SEK
5/27/20265.75 SEK
5/26/20265.90 SEK
5/25/20266.03 SEK
5/22/20266.00 SEK
5/21/20265.69 SEK
5/20/20266.09 SEK
5/19/20265.90 SEK
5/18/20266.06 SEK
5/15/20266.06 SEK
5/13/20265.87 SEK
5/12/20265.87 SEK
5/11/20265.87 SEK
5/8/20266.00 SEK
5/7/20266.03 SEK
5/6/20266.03 SEK
5/5/20266.06 SEK
5/4/20266.12 SEK
4/30/20266.12 SEK
4/29/20266.28 SEK
4/28/20266.28 SEK
4/27/20266.21 SEK
4/24/20266.09 SEK
4/23/20266.00 SEK
4/22/20266.09 SEK
4/21/20266.09 SEK
4/20/20266.09 SEK
4/17/20266.28 SEK
4/16/20266.06 SEK
4/15/20266.21 SEK
4/14/20265.90 SEK
4/13/20265.96 SEK
4/10/20266.21 SEK
4/9/20266.46 SEK
4/8/20266.28 SEK
4/7/20266.83 SEK
4/2/20266.83 SEK
4/1/20266.83 SEK
3/31/20266.60 SEK
3/30/20266.52 SEK
3/27/20267.07 SEK
3/26/20267.11 SEK
3/25/20267.11 SEK
3/24/20267.03 SEK
3/23/20267.30 SEK
3/20/20267.30 SEK
3/19/20267.30 SEK
3/18/20267.30 SEK
3/17/20267.11 SEK
3/16/20267.30 SEK
3/13/20267.19 SEK
3/12/20267.50 SEK
3/11/20267.50 SEK
3/10/20267.50 SEK
3/9/20267.23 SEK
3/6/20267.42 SEK
3/5/20267.50 SEK
3/4/20267.50 SEK
3/3/20267.50 SEK
3/2/20267.50 SEK
2/27/20267.50 SEK
2/26/20267.46 SEK
2/25/20267.50 SEK
2/24/20267.69 SEK
2/23/20267.62 SEK
2/20/20267.81 SEK
2/19/20268.12 SEK
2/18/20268.32 SEK
2/17/20268.01 SEK
2/16/20268.47 SEK
2/13/20268.51 SEK
2/12/20268.47 SEK
2/11/20268.24 SEK
2/10/20268.24 SEK
2/9/20268.51 SEK
2/6/20268.87 SEK
2/5/20268.51 SEK
2/4/20268.79 SEK
2/3/20268.51 SEK
2/2/20268.28 SEK
1/30/20268.20 SEK
1/29/20268.71 SEK
1/28/20268.40 SEK
1/27/20268.08 SEK
1/26/20268.08 SEK
1/23/20268.12 SEK
1/22/20268.12 SEK
1/21/20267.85 SEK
1/20/20267.81 SEK
1/19/20267.81 SEK
1/16/20267.81 SEK
1/15/20268.12 SEK
1/14/20267.81 SEK
1/13/20267.71 SEK
1/12/20267.61 SEK
1/9/20267.62 SEK
1/8/20267.81 SEK
1/7/20267.81 SEK
1/5/20267.81 SEK
1/2/20267.81 SEK
12/30/20257.72 SEK
12/29/20258.01 SEK
12/23/20258.32 SEK
12/22/20258.59 SEK
12/19/20258.44 SEK
12/18/20258.11 SEK
12/17/20258.21 SEK
12/16/20258.40 SEK
12/15/20258.30 SEK
12/12/20259.18 SEK
12/11/20259.39 SEK
12/10/20259.18 SEK
12/9/20259.17 SEK
12/8/20259.84 SEK
12/5/20259.80 SEK
12/4/20259.57 SEK
12/3/20258.79 SEK
12/2/20258.98 SEK
12/1/20258.89 SEK
11/28/20259.14 SEK
11/27/20259.16 SEK
11/26/20258.98 SEK
11/25/20259.12 SEK
11/24/20259.35 SEK
11/21/20259.55 SEK
11/20/20259.18 SEK
11/19/20259.76 SEK
11/18/20259.28 SEK
11/17/20259.76 SEK
11/14/20258.71 SEK
11/13/20258.81 SEK
11/12/20259.26 SEK
11/11/20259.30 SEK
11/10/20259.08 SEK
11/7/20258.96 SEK
11/6/20259.35 SEK
11/5/20258.79 SEK
11/4/20259.20 SEK
11/3/20259.20 SEK
10/31/20259.18 SEK
10/30/20259.04 SEK
10/29/20259.55 SEK
10/28/20259.49 SEK
10/27/20259.18 SEK
10/24/20259.20 SEK
10/23/20259.43 SEK
10/22/20259.72 SEK
10/21/20259.74 SEK
10/20/20259.76 SEK
10/17/20258.90 SEK
10/16/20259.28 SEK
10/15/20259.53 SEK
10/14/20259.88 SEK
10/13/20259.57 SEK
10/10/20259.84 SEK
10/9/20259.88 SEK
10/8/20259.88 SEK
10/7/202510.19 SEK
10/6/202510.43 SEK
10/3/20259.88 SEK
10/2/20259.71 SEK
10/1/202510.15 SEK
9/30/202510.12 SEK
9/29/202510.51 SEK
9/26/202510.27 SEK
9/25/202510.23 SEK
9/24/202510.23 SEK
9/23/20259.80 SEK
9/22/20259.16 SEK
9/19/20259.53 SEK
9/18/20259.39 SEK
9/17/20259.28 SEK
9/16/20259.35 SEK
9/15/20259.02 SEK
9/12/20258.40 SEK
9/11/20258.46 SEK
9/10/20258.49 SEK
9/9/20258.94 SEK
9/8/20258.90 SEK
9/5/20258.59 SEK
9/4/20259.20 SEK
9/3/20258.94 SEK
9/2/20259.43 SEK
9/1/20258.77 SEK
8/29/20258.73 SEK
8/28/20259.00 SEK
8/27/20259.61 SEK
8/26/20259.51 SEK
8/25/20259.61 SEK
8/22/20259.39 SEK
8/21/20259.74 SEK
8/20/20259.35 SEK
8/19/20259.84 SEK
8/18/20259.57 SEK
Access this data via the Eulerpool API
Get Free API Key

Biosergen Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2020
0.00 SEK
-6.23 M SEK
-6.72 M SEK
Jan 1, 2021
0.00 SEK
-34.08 M SEK
-34.32 M SEK
Jan 1, 2022
0.00 SEK
-34.13 M SEK
-34.05 M SEK
Jan 1, 2023
0.00 SEK
-27.27 M SEK
-27.04 M SEK
Jan 1, 2024 (e)
1.62 M SEK
-25.25 M SEK
-47.47 M SEK
Jan 1, 2025 (e)
0.00 SEK
-21.61 M SEK
-213,614.99 SEK
Jan 1, 2026 (e)
1.41 M SEK
-21.51 M SEK
-213,614.99 SEK
Jan 1, 2027 (e)
261.69 M SEK
238.87 M SEK
2.33 M SEK

Biosergen Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 15, 2026, 10:07 AM
 
REVENUEM SEK
REVENUE GROWTH%
EBITM SEK
EBIT MARGIN%
NET INCOMEM SEK
NET INCOME GROWTH%
SHARESk
20202021202220232024e2025e2026e2027e
––––1.00–1.00261.00
–––––––26,000.00
-6.00-34.00-34.00-27.00-25.00-21.00-21.00238.00
––––-2,500.00–-2,100.0091.19
-6.00-34.00-34.00-27.00-47.00––2.00
–466.67–-20.5974.07–––
534.90534.90717.60862.80862.80862.80862.80862.80
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Biosergen generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Biosergen retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Biosergen's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Biosergen has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Biosergen's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Biosergen stock margins

The Biosergen margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Biosergen. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Biosergen.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
0.00 %
- %
- %
Jan 1, 2021
0.00 %
- %
- %
Jan 1, 2022
0.00 %
- %
- %
Jan 1, 2023
0.00 %
- %
- %
Jan 1, 2024 (e)
0.00 %
-1,562.50 %
-2,937.50 %
Jan 1, 2025 (e)
0.00 %
- %
- %
Jan 1, 2026 (e)
0.00 %
-1,521.43 %
-15.11 %

Biosergen Stock Revenue, EBIT, Earnings per Share

The Biosergen earnings per share therefore indicates how much revenue Biosergen has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.00 SEK
-1,163.96 SEK
-1,257.06 SEK
Jan 1, 2021
0.00 SEK
-6,370.91 SEK
-6,415.78 SEK
Jan 1, 2022
0.00 SEK
-4,755.99 SEK
-4,744.71 SEK
Jan 1, 2023
0.00 SEK
-3,160.06 SEK
-3,133.63 SEK
Jan 1, 2024 (e)
68.77 SEK
-2,926.52 SEK
-2,020.00 SEK
Jan 1, 2025 (e)
0.00 SEK
-2,505.10 SEK
-9.09 SEK
Jan 1, 2026 (e)
60.17 SEK
-2,493.39 SEK
-9.09 SEK

Biosergen business model & stock analysis

Biosergen Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Biosergen historical P/E ratio, EBIT multiple, and P/S ratio

Biosergen annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Biosergen shares outstanding

The number of shares of Biosergen was 8,628 in 2025. This indicates how many shares Biosergen is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
5,349.00 Stocks
Jan 1, 2021
5,349.00 Stocks
Jan 1, 2022
7,176.00 Stocks
Jan 1, 2023
8,628.00 Stocks
Jan 1, 2024 (e)
8,628.00 Stocks
Jan 1, 2025 (e)
8,628.00 Stocks
Jan 1, 2026 (e)
8,628.00 Stocks

Biosergen stock splits

In Biosergen's history, there have been no stock splits.
Price targets and forecasts for Biosergen are not yet available.

Biosergen shareholder structure

% Name
42.01409%
Östersjöstiftelsen
Östersjöstiftelsen
15.53191%
Ribbskottet AB
Ribbskottet AB
6.17745%
Rosetta Capital Limited
Rosetta Capital Limited
0.01830%
FCG Fonder AB
FCG Fonder AB

Biosergen Executives and Management Board

10 members · avg. age 64

Management

PM

Peder Møller Andersen, MD (70)

Chief Executive Officer

–
NM

Niels Laursen, MBA (66)

Chief Financial Officer

–
RP

Richard Forster, PhD

Chief Technology Officer

–

Board of Directors

TP

Torsten Rüdiger Goesch, MD, PhD (63)

Chairman · since 2015

–
MM

Mattias Klintemar, MBA (55)

Director · since 2021

–
LP

Lena Birgitta Degling Wikingsson, PhD (59)

Independent Director · since 2021

–
AP

Achim Kaufhold, MD, PhD (64)

Independent Director · since 2021

–
ME

Marianne Kock, EMBA (67)

Independent Director · since 2021

–
HM

Hanne Mette Dyrlie Kristensen, MBA

Independent Director · since 2021

–

Frequently asked questions about Biosergen

Converted at the current exchange rate, the Biosergen share trades at 0.11 EUR (1.25 SEK).

No history available for Biosergen.

The expected revenue of Biosergen is 1.41 M SEK. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Biosergen is -213,614.99 SEK. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Biosergen is currently -0.05. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Biosergen stock.

The price-to-sales ratio (P/S) of Biosergen is currently 0.01. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Biosergen stock.

The Eulerpool Quality Score for Biosergen is 2/10.

The ISIN of Biosergen is SE0026821852. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Biosergen is A3CSG0. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Biosergen is BIOSGN.ST. The ticker symbol is used to trade Biosergen shares on the stock exchange.

Biosergen paid dividends every year for the past 0 years.

Biosergen is assigned to the 'Health' sector.

The dividends of Biosergen are distributed in SEK.

All fundamentals and in-depth analysis of Biosergen

Our stock analysis for Biosergen stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biosergen. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Biosergen Stock
Biosergen Revenue→
Biosergen Stock
Biosergen Net Income→
Biosergen Stock
Biosergen P/E→
Biosergen Stock
Biosergen P/S→
Biosergen Stock
Biosergen EBIT→
Biosergen Stock
Biosergen Dividend→
Biosergen Stock
Biosergen Directors Dealings→
Biosergen Stock
Biosergen Stocks→
Biosergen Stock
Biosergen Market capitalization→
Biosergen Stock
Biosergen Debt→
Biosergen Stock
Biosergen Liabilities→
Biosergen Stock
Biosergen Equity→
Biosergen Stock
Biosergen AAQS→
Biosergen Stock
Biosergen Employees→
Biosergen Stock
Biosergen ROE→
Biosergen Stock
Biosergen ROA→
Biosergen Stock
Biosergen ROCE→
Biosergen Stock
Biosergen News→
Biosergen Stock
Biosergen Analyst Price Targets→

Health Stocks

Biosino Bio-Technology and ScienceBiosenicBiostar PharmaceuticalsBioscience Animal Health PCLBiostaxBioretec OyBiostem TechnologiesBioRestorative TherapiesBioSyentBioray Biotech CoBiosynexBiora TherapeuticsAll Stocks A–Z →